XML 59 R46.htm IDEA: XBRL DOCUMENT
v3.22.1

SHAREHOLDERS’ DEFICIT (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
Schedule of warrants issued and outstanding |
Schedule of warrants issued and outstanding |  |  |  |  |  |  |  |  |  |  |  |
|  | Warrants |  | Weighted average exercise price |  | Weighted average remaining contractual life (in years)
Outstanding as of December 31, 2019 (a) |  |  | 21,000 |  |  | $ | 0.0001 |  |  |  | 1.3 |
Issued (b) |  |  | 4,094 |  |  | $ | 420 |  |  |  | 0.9 |
Exercised |  |  | (21,838 | ) |  | $ | (6.34 | ) |  |  | 1 |
Expired |  |  | (1,209 | ) |  | $ | (420 | ) |  |  | (0.6 | )
Outstanding as of December 31, 2020 (b) |  |  | 2,047 |  |  | $ | 420 |  |  |  | 0.6 |
Issued (b) |  |  | 2,120 |  |  | $ | 420 |  |  |  | 0.5 |
Issued (a) |  |  | 144,445 |  |  | $ | 9.90 |  |  |  | 5.0 |
Exercised (b) |  |  | (307 | ) |  | $ | (420 | ) |  |  | — |
Expired |  |  | — |  |  | $ | — |  |  |  | — |
Outstanding as of December 31, 2021 |  |  | 148,305 |  |  | $ | 20.57 |  |  |  | 4.88 |
(a) | Common stock will be issued if those warrants exercise The 144,445 warrants having intrinsic value of $73,667 as of December 31, 2021.
(b) | Preferred stock series C-1 will be issued if those warrants exercise. Further, those preferred stock series C-1 will automatically convert into the 1,158,000 and 614,400 common stock with the intrinsic value of $10,433,580 and nil as of December 31, 2021 and 2020, respectively.
Schedule of Stock Award |
Schedule of Stock Option |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Share option |  | Weighted average exercise price |  | Weighted average remaining contractual life (in years)
Outstanding as of December 31, 2019 |  |  |  | — |  |  | $ | — |  |  |  | — |
Granted |  |  |  | — |  |  |  | — |  |  |  | — |
Exercised |  |  |  | — |  |  |  | — |  |  |  | — |
Expired |  |  |  | — |  |  |  | — |  |  |  | — |
Outstanding as of December 31, 2020 |  |  |  | — |  |  |  | — |  |  |  | — |
Granted |  |  |  | 1,945,270 |  |  |  | 6.49 |  |  |  | 10 |
Exercised |  |  |  | — |  |  |  | — |  |  |  | — |
Expired |  |  |  | — |  |  |  | — |  |  |  | — |
Outstanding as of December 31, 2021 |  |  |  | 1,945,270 |  |  | $ | 6.49 |  |  |  | 10 |
Warrant [Member] |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
Schedule of Stock option assumptions |
Schedule of Stock option assumptions |  |  |  |  |  |  |  |
|  | Before modification |  | After Modification
Dividend rate |  |  | 0 | % |  |  | 0 | %
Risk-free rate |  |  | 0.06 | % |  |  | 0.12 | %
Weighted average expected life (years) |  |  | 9 months |  |  |  | 18 months |
Expected volatility |  |  | 25 | % |  |  | 25 | %
Exercise price |  | $ | 1.4 |  |  | $ | 1.4 |
(a) | The Company considered 25% volatility as from inception through the date of the Company common stocks.
Equity Option [Member] |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
Schedule of Stock option assumptions |
Schedule of Stock option assumptions |  |  |  |
|  | December 31, 2021
Dividend rate |  |  | 0 | %
Risk-free rate |  |  | 1.52 | %
Weighted average expected life (years) |  |  | 10 years |
Expected volatility |  |  | 130 | %
Share price |  | $ | 6.49 |
Stock Awards Axis [Member] |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
Schedule of Stock Award |
Schedule of Stock Award |  |  |  |  |  |  |  |  |  |  |  |
Unvested as of December 31, 2019 |  |  | — |  |  | $ | — |  |  |  | — |
Issued |  |  | — |  |  |  | — |  |  |  | — |
Vested |  |  | — |  |  |  | — |  |  |  | — |
Cancelled |  |  | — |  |  |  | — |  |  |  | — |
Unvested as of December 31, 2020 |  |  | — |  |  |  | — |  |  |  | — |
Issued |  |  | 814,950 |  |  |  | 7.65 |  |  |  | 2 years |
Vested |  |  | (162,990 | ) |  |  | 7.65 |  |  |  | — |
Cancelled |  |  | — |  |  |  | — |  |  |  | — |
Unvested as of December 31, 2021 |  |  | 651,960 |  |  | $ | 7.65 |  |  |  | 1.67 years |
Shares Unvested at period-end |  |  | 651,960 |  |  | $ | 7.65 |

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_StockOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=SOPA_StockAwardsAxisMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |